Rimonabant was granted marketing authorisation in the EU in June 2006. Currently, acomplia (rimonabant) has been launched in 19 countries, including 13 European countries. Up to the end of May 2007, it is estimated that about 240,000 patients have been …

Orlistat, a weight loss medication previously only available via prescription in the drug called Xenical, may soon become available over-the-counter.

GlaxoSmithKline Consumer Healthcare has announced that an FDA committee voted 11 to 3 to recommend approval of orlistat 60 mg …

At the European Society of Cardiology Congress, new data was reported on the effectiveness of rimonabant for treating obesity. Rimonabant, an investigational drug from Sanofi-Aventis, is aimed at helping patients lose weight and quit smoking.

n this most recent trial, the …

Advancement in technology came as a boon for the world. However, it took away from the people living here the quality of patience. The generation of today would prefer to do anything rather than wait patiently for results. An instance …